NCT04476602

Completed

Ambulatory Management of Moderate to High Risk COVID-19 (SAR...

Northwell Health Source

Compare

Other study identifiers

Sponsor study identifier

20-0618

Study Type

observational

Actual enrollment (reported)

182

Locations

1 country

Sites

1

Timeline

Study Start

April 27, 2020

Actual (reported)

Primary Completion

October 15, 2020

Actual (reported)

Study Completion

October 15, 2020

Actual (reported)

Brief Summary

Descriptive report of the Northwell CROWN program for ambulatory treatment of COVID-19 (SARS-CoV-2) patients with moderate to high risk features

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 182 participants
Study completion date: October 15, 2020
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
April 27, 2020
Actual (reported)
First Submitted
July 16, 2020
Actual (reported)
First Posted
July 20, 2020
Actual (reported)
Primary Completion
October 15, 2020
Actual (reported)
Study Completion
October 15, 2020
Actual (reported)

Last Updated: July 14, 2022
Status Verified: July 2022
Last Update Submitted: July 13, 2022

Conditions

Covid-19 (SARS-CoV-2)

Keywords

COVID-19 (SARS-CoV-2)HomecareAmbulatory

Outcome Measures

Primary Outcomes (1)

Hospital Admission
admission to hospital
30 days

Study Arms (1)

COVID-19 (SARS-CoV-2) patients

adults 18 or older, ambulatory , with COVID-19 (SARS-CoV-2)

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

General public

You may qualify if:

COVID-19 (SARS-CoV-2) infection Ambulatory

You may not qualify if:

Sponsors & Collaborators

Northwell Health
Otherlead

Study Sites (1)

410 Lakeville Road, Suite 107

New Hyde Park, New York, 11042, United States

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

Gita Lisker, MD
Northwell Health
PRINCIPAL INVESTIGATOR
ramona ramdeo
Northwell Health
STUDY DIRECTOR

Enrollment

182 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Physician

Study Record Dates

First Submitted

July 16, 2020

First Posted

July 20, 2020

Study Start

April 27, 2020

Actual (reported)

NCT05057897

A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised Adults

Phase 4Terminated

NCT06057064

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Phase 2Completed

NCT04590261

Myeloid Cells in Patients With Covid-19 Pneumonia

Not ApplicableWithdrawn

NCT05932641

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

Phase 1Completed

NCT05648110

Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)

Phase 2/3Completed

NCT06851611

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

Phase 1Completed

Need for hospital admission

Contact the study team to confirm eligibility.

Primary Completion

October 15, 2020

Actual (reported)

Study Completion

October 15, 2020

Actual (reported)

Last Updated

July 14, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04476602
Data provider: ClinicalTrials.gov
Source updated: 2022-07-14
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:58 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

COVID-19 (SARS-CoV-2) patients

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations